" class="no-js "lang="en-US"> UCB - Medtech Alert
Tuesday, May 28, 2024
UCB | Pharmtech Focus

UCB

About UCB

UCB

UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients.

Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?”
And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.

UCB – The Facts

With more than 7600 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 20% of revenue in cutting-edge scientific research to meet unmet patient needs.
A few other reasons that make UCB an amazing place to work:
– Promising pipeline that includes several novel molecules;
– 2020 Key Financials: €5.3 billion global revenue

Specialties: Neurology, Immunology

Related Story

Huma and UCB to Provide Digital Health Solution for Myasthenia Gravis

April 26 2023

Huma Therapeutics, a leading global digital health company, and UCB, a global biopharmaceutical company, are […]

Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease

March 16 2023

UCB, a global biopharmaceutical company, and Aitia, the leader in the application of Causal AI […]